Skip to main content

Advertisement

Log in

Ethical Challenges Posed by the Ebola Virus Epidemic in West Africa

  • Critical Perspectives
  • Published:
Journal of Bioethical Inquiry Aims and scope Submit manuscript

Abstract

This paper examines how people in West Africa are reacting to the Ebola virus disease, an epidemic presently prevalent in the region. Certain lifestyle changes are suggested. Additionally, the heart of the paper focuses on the request by governments to be allowed access to experimental drugs, such as Zmapp and TKM-Ebola, for their infected populations. The author argues that granting such a request would circumvent research ethics procedures, which could potentially constitute significant risk to users of the drugs. The Pfizer Kano meningitis trial of 1996 is cited as an example to buttress how unapproved drugs could prove fatal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter F. Omonzejele.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omonzejele, P.F. Ethical Challenges Posed by the Ebola Virus Epidemic in West Africa. Bioethical Inquiry 11, 417–420 (2014). https://doi.org/10.1007/s11673-014-9587-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11673-014-9587-3

Keywords

Navigation